Comparison of the Effect of Propacetamol, Ibuprofen or Their Combination on Postoperative Pain and Quality of Recovery After Laparoscopic Hernia Repair in Children
Launched by YONSEI UNIVERSITY · Nov 20, 2017
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • scheduled to undergo laparoscopic inguinal hernia surgery
- • American Society of Anesthesiologists physical status classification 1 or 2
- • Children aged 6 months to 6 years
- Exclusion Criteria:
- • history of Gastrointestinal bleeding
- • history or laboratory finding of suspected renal or hepatic dysfunction
- • bronchial asthma
- • bleeding disorder
- • hypersensitivity to NSAID or propacetamol
- • disagreement of investigation
- • The researcher determines that participation is inappropriate due to other reasons.
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials